KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

10.69 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32002 Q22002 Q12001 Q3
Revenue 01.2060000000000012.690003.8241.5773.923.3692.9263.895.5923.7184.842.3311.1270.0960.1140.24800.0070.0070.0080.0070.0070.0070.0080.010.0050.0060.398033.5790
Cost of Revenue 0.2240.2190.2070.1970.1990.3240.2090.19218.1860.182000000000000000000000000000000000000
Gross Profit -0.2240.987-0.207-0.197-0.199-0.324-0.209-0.192-18.186-0.18200012.690003.8241.5773.923.3692.9263.895.5923.7184.842.3311.1270.0960.1140.24800.0070.0070.0080.0070.0070.0070.0080.010.0050.0060.398033.5790
Gross Profit Ratio 00.81800000000000100011111111111111011111111111010
Reseach & Development Expenses 26.61425.24822.52319.08919.30723.95120.06318.07718.18619.21319.73817.54613.66911.8779.0979.14811.1659.48511.2339.7899.68611.1397.657.8768.3565.8524.5484.3613.4762.9963.3390.3320.3323.5324.263.5334.5043.9023.0312.0881.751.4251.11618.077-3.21120.063
General & Administrative Expenses 17.60123.20710.62810.6579.7867.7776.8827.8068.137.5986.9456.0575.8476.1653.563.6333.2783.2963.0683.423.2473.0472.92.6092.3711.9572.1292.7032.0732.2045.0262.082.081.5431.3171.3731.171.0060.7941.490.6910.4370.3687.80606.882
Selling & Marketing Expenses -0.2240.207-0.2070000000000000000000000000000000000000000000
SG&A 17.37722.98810.42110.6579.7867.7776.8827.8068.137.5986.9456.0575.8476.1653.563.6333.2783.2963.0683.423.2473.0472.92.6092.3711.9572.1292.7032.0732.2045.0262.082.081.5431.3171.3731.171.0060.7941.490.6910.4370.3687.80606.882
Other Expenses 1.566-7.3452.3192.6192.3974.2884.3133.4943.5493.4384.1563.9433.1842.6392.1712.1862.9322.4982.9232.3212.0892.5111.7331.6161.8231.9850.9850.8670.5551.0190.66104.88-0.003-0.0030.001-0.0010.553-0.335-0.071-0.117-0.079-0.06303.2330
Operating Expenses 43.99148.23632.94429.74629.09331.72826.94525.88326.31626.81126.68323.60319.51618.04212.65712.78114.44312.78114.30113.20912.93314.18610.5510.48510.7277.8096.6777.0645.5495.28.3652.4122.4125.0755.5774.9065.6744.9083.8253.5782.4411.8621.48425.8830.02226.945
Operating Income -44.215-48.455-33.151-29.746-29.093-31.728-26.945-25.883-26.316-26.811-26.683-23.603-19.516-18.042-12.657-12.781-14.443-8.957-12.724-9.289-9.564-11.26-6.66-4.893-7.009-2.969-4.346-5.937-5.453-5.086-8.117-2.405-2.405-6.528-5.569-4.899-5.667-4.901-3.817-3.568-2.436-1.856-1.086-22.2570-21.303
Operating Income Ratio 0-40.17800000000000-1.422000-2.342-8.068-2.37-2.839-3.848-1.712-0.875-1.885-0.613-1.864-5.268-56.802-44.614-32.730-343.571-932.571-696.125-699.857-809.571-700.143-477.125-356.8-487.2-309.333-2.729000
Total Other Income Expenses Net 3.7723.8054.1231.322.8535.4235.6423.6263.0322.6983.9583.6633.1332.7712.4722.1623.371.8853.0612.8811.6362.4771.9811.3851.892.247-0.9020.950.5230.8790.46600.02-1.463-0.0030.001-3.1780.553-0.335-0.071-0.117-0.079-0.063000
Income Before Tax -40.443-44.65-29.028-27.65-25.317-26.305-21.303-22.257-23.042-24.113-22.467-19.65-16.109-14.957-10.048-10.426-10.814-6.709-9.291-5.903-7.338-8.402-3.956-3.304-5.03-0.657-5.234-4.986-4.928-4.202-7.6440-2.385-6.607-5.659-4.991-9.012-5.184-4.714-3.995-2.635-2.015-1.207-22.257-16.109-21.303
Income Before Tax Ratio 0-37.02300000000000-1.179000-1.754-5.892-1.506-2.178-2.871-1.017-0.591-1.353-0.136-2.245-4.424-51.333-36.86-30.8230-340.714-943.857-707.375-713-1,287.429-740.571-589.25-399.5-527-335.833-3.0330-0.480
Income Tax Expense 00.85600.523-1.37913.728-6.971-3.7580.275-1.958-4.276-3.963-3.63-3.532-3.047-2.524-4.326-0.124-3.943-3.946-1.7730.124-2.952-1.358-2.046-2.5742.775-1.034-0.493-0.744-0.4730-0.020.3860.090.0960.0923.1770.8970.4270.1990.1590.121016.1090
Net Income -40.443-44.65-29.028-27.65-25.317-40.033-14.332-18.499-23.042-22.155-22.467-19.65-16.109-14.957-10.048-10.426-10.814-6.585-9.291-5.903-7.338-8.526-3.956-3.304-5.03-0.657-5.234-4.986-4.928-4.202-7.6440-2.365-6.607-5.659-4.991-9.012-5.184-4.714-3.995-2.635-2.015-1.207-22.257-16.109-21.303
Net Income Ratio 0-37.02300000000000-1.179000-1.722-5.892-1.506-2.178-2.914-1.017-0.591-1.353-0.136-2.245-4.424-51.333-36.86-30.8230-337.857-943.857-707.375-713-1,287.429-740.571-589.25-399.5-527-335.833-3.0330-0.480
EPS -0.87-1.02-0.84-0.8-0.74-1.17-0.51-0.75-0.94-0.9-0.92-0.8-0.66-0.65-0.56-0.58-0.61-0.37-0.52-0.33-0.42-0.49-0.23-0.22-0.47-0.061-0.49-0.5-0.51-0.43-10-3.52-3.51-3.01-2.65-5.58-2.99-6.5-5.51-3.64-2.78-1.67-0.0010-0.001
EPS Diluted -0.87-1.02-0.84-0.8-0.74-1.17-0.51-0.75-0.94-0.9-0.92-0.8-0.66-0.65-0.56-0.58-0.61-0.37-0.52-0.33-0.42-0.49-0.23-0.22-0.47-0.061-0.49-0.5-0.51-0.43-10-3.52-3.51-3.01-2.65-5.58-2.99-6.5-5.51-3.64-2.78-1.67-0.0010-0.001
EBITDA -43.991-48.236-32.944-28.25-29.356-31.867-27.542-25.393-25.641-25.803-26.336-23.196-19.333-18.174-12.822-12.624-14.753-8.344-12.583-9.587-8.852-11.226-6.805-4.559-7.026-3.231-2.409-5.973-5.389-4.946-7.922-2.405-2.385-5.025-5.536-4.863-5.632-4.317-4.135-3.621-2.542-1.925-1.143-22.2570.132-21.303
EBITDA Ratio 0-39.99700000000000-1.432000-2.182-7.979-2.446-2.627-3.837-1.749-0.815-1.89-0.668-1.033-5.3-56.135-43.386-31.9440-340.714-717.857-692-694.714-804.571-616.714-516.875-362.1-508.4-320.833-2.87200.0040